G
Galectin Therapeutics Inc. (GALT)
NCM – Real Time Price. Currency in USD
2.68
-0.12 (-4.29%)
At close: Mar 27, 2026, 4:00 PM EDT
2.80
+0.12 (4.48%)
After-hours: Mar 27, 2026, 5:49 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.68
-0.12 (-4.29%)
At close: Mar 27, 2026, 4:00 PM EDT
2.80
+0.12 (4.48%)
After-hours: Mar 27, 2026, 5:49 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.09 | 6.05 | 1.0 | |
| Quick ratio | 0.09 | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 9.51 | 1.04 | 1.0 | |
| Interest coverage | -2.31 | -16.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -41K | -32K | -33K | -37K | -22K |
| Operating Income | -30M | -38M | -38M | -42M | -29M |
| Net Income | -31M | -39M | -41M | -47M | -37M |
| EBITDA | -30M | -38M | -38M | -42M | -29M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 47.37 | 5.5 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | 35.53 | 5.5 |
| Next year | N/A | 16.33 | 5.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -8.81 | -8.32 | 46.35 | 5.5 |
| Y/Y | 999 | 27.06 | 27.78 | 58.51 | 10 |
| 3y average | 999 | -15.81 | -13.83 | -20.18 | 3.3 |
| 5y average | 999 | -30.8 | -14.68 | -33.68 | 3.3 |
| Weighted average score | 5.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $122.3M significantly exceeds cash reserves ($11.5M), raising financial stability concerns
Total current liabilities $136.4M surpass Total current assets $12.7M, signaling liquidity issues
Debt-to-equity ratio (-1.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-2.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.5M limits the company's ability to reinvest or pay down debt